A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2026

Conditions

UveitisYUTIQ

Interventions

DRUG

Yutiq

YUTIQ® 0.18 mg as an intravitreal injection in the designated study eye.

Trial Locations (1)

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors

lead

Tianjin Medical University

OTHER